AnGes, Inc. / Japan
台灣醫療科技展展位:n/a
AnGes is a commercial stage biopharmaceutical company focused on the development and commercialization of novel gene-based medicines. Our key products include Collategene, HGF plasmid for critical limb ischemia (CLI) and NFkB Decoy Oligo for Inflammatory diseases.
 
成立時間1999
資本額TWD 0
員工數80
產品/服務類別
基因醫學 生技製藥 防疫科技
採購與合作需求項目
First-in-class innovative clinical development projects
供應與銷售項目
Partner for our flagship gene therapy product Collategene (HGF plasmid for Critical Limb Ischemia)
最新商機情報
你可能有興趣的產品服務
你可能有興趣的機構/企業
© Institute for Biotechnology and Medicine Industry & Research Center for Biotechnology and Medicine Policy
聯絡我們
Loading...